Latest Share Based Payments News

Page 12 of 21
Biome Australia has delivered a standout FY26 with sales up 30% to $23.9 million and net profit after tax soaring to $3.6 million, bolstered by a non-cash deferred tax asset. The company strengthened its balance sheet while expanding manufacturing and international distribution.
Ada Torres
Ada Torres
26 Aug 2026
NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.
Ada Torres
Ada Torres
25 Aug 2026
Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.
Ada Torres
Ada Torres
25 Aug 2026
Prescient Therapeutics cut its net loss by 4.4% to $7 million in FY26 while expanding its PTX-100 Phase 2a trial across three continents and securing key regulatory designations in Europe and the US.
Ada Torres
Ada Torres
21 Aug 2026
PlaySide Studios reversed a prior-year loss with a 13% revenue increase to $54.9 million and a 144% jump in net profit to $5.4 million, driven by strong Original IP sales and a strategic cost restructure.
Sophie Babbage
Sophie Babbage
20 Aug 2026
Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.
Ada Torres
Ada Torres
19 Aug 2026
Audinate Group Limited reported a 15% revenue increase driven by its expanding Dante ecosystem and Iris acquisition, but underlying EBITDA losses widened amid restructuring and investment costs.
Sophie Babbage
Sophie Babbage
17 Aug 2026
Tarrina Resources (ASX:TR8) posted a $3.63 million loss for FY2026 as it ramped up exploration at its newly acquired gold and base metal projects following a $5 million capital raise and ASX relisting.
Maxwell Dee
Maxwell Dee
14 Aug 2026
Microequities Asset Management Group saw a 20.1% drop in profit after tax for FY26, hit by sharp valuation falls in tech-heavy portfolios amid AI fears, despite a 1.5% revenue rise and a strong balance sheet.
Claire Turing
Claire Turing
14 Aug 2026
Black Horse Mining Limited completed an $8 million IPO and acquired an 80% stake in the Mt Egerton Gold Project holder. The company reported a $5.87 million loss for FY26, driven by exploration costs and significant share-based payments.
Maxwell Dee
Maxwell Dee
11 Aug 2026
Infinity Metals has locked in an exclusive option to acquire 100% of the Tule Canyon molybdenum-copper project in Nevada, a historically explored porphyry deposit with promising drill results and strategic positioning amid soaring molybdenum prices.
Maxwell Dee
Maxwell Dee
5 Aug 2026
Verbrec Limited confirms a robust FY2026 with revenues up nearly 50%, while unveiling a bullish FY2027 outlook driven by full-year Alliance Automation integration and expanding project pipelines.
Victor Sage
Victor Sage
27 July 2026

Browse the archive

Full archive